In particular, our study has demonstrated the variation of ACE2 expression in cells obtained from nasopharyngeal swabs of COVID-19 individuals who have not received vaccines against SARS-CoV-2, analyzed using the immunofluorescence technique and from a gender and hormonal perspective. The gene discussed is ACE2; the disease is COVID-19.